Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

EuroIntervention. 2020 Dec 4;16(11):e938-e941. doi: 10.4244/EIJ-D-20-00024.
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Absorbable Implants
  • Coronary Artery Disease* / diagnostic imaging
  • Coronary Artery Disease* / surgery
  • Drug-Eluting Stents*
  • Everolimus
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Prosthesis Design
  • Stents
  • Treatment Outcome

Substances

  • Everolimus